ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B0M62Q58
Stock Name / FundiShares MSCI World UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300YDM1GFZR5B4U80
ETF TickerIDWR(USD) LSE
ETF TickerIQQW(EUR) F
ETF TickerIDWR.LS(USD) CXE
ETF TickerIQQW.DE(EUR) CXE
ETF TickerIWRD.AS(EUR) CXE
ETF TickerIWRD.LS(GBX) CXE
ETF TickerIWRD.MI(EUR) CXE
ETF TickerIWRDz(USD) CXE
ETF TickerIWRD(EUR) ETF Plus
ETF TickerIDWR.L(GBP) LSE

Holdings detail for LLY

Stock NameEli Lilly and Company
TickerLLY(EUR) F
TYPECommon Stock
CountryGermany
ISINUS5324571083
LEIFRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About
Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today
Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock
Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years
Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever
Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years
Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!
My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks
In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly
In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis
Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now
Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares MSCI World UCITS ETF USD (Dist) LLY holdings

DateNumber of LLY Shares HeldBase Market Value of LLY SharesLocal Market Value of LLY SharesChange in LLY Shares HeldChange in LLY Base ValueCurrent Price per LLY Share HeldPrevious Price per LLY Share Held
2025-11-27 (Thursday)84,655USD 93,487,903USD 93,487,9030USD 0 USD 1104.34 USD 1104.34
2025-11-26 (Wednesday)84,655LLY holding decreased by -160USD 93,487,903LLY holding decreased by -651658USD 93,487,903-160USD -651,658 USD 1104.34 USD 1109.94
2025-11-25 (Tuesday)84,815USD 94,139,561LLY holding increased by 3373941USD 94,139,5610USD 3,373,941 USD 1109.94 USD 1070.16
2025-11-24 (Monday)84,815USD 90,765,620LLY holding increased by 887164USD 90,765,6200USD 887,164 USD 1070.16 USD 1059.7
2025-11-21 (Friday)84,815USD 89,878,456LLY holding increased by 1391815USD 89,878,4560USD 1,391,815 USD 1059.7 USD 1043.29
2025-11-20 (Thursday)84,815USD 88,486,641LLY holding decreased by -535183USD 88,486,6410USD -535,183 USD 1043.29 USD 1049.6
2025-11-19 (Wednesday)84,815USD 89,021,824LLY holding increased by 1658133USD 89,021,8240USD 1,658,133 USD 1049.6 USD 1030.05
2025-11-18 (Tuesday)84,815USD 87,363,691LLY holding increased by 708205USD 87,363,6910USD 708,205 USD 1030.05 USD 1021.7
2025-11-17 (Monday)84,815USD 86,655,486LLY holding decreased by -303637USD 86,655,4860USD -303,637 USD 1021.7 USD 1025.28
2025-11-14 (Friday)84,815LLY holding decreased by -160USD 86,959,123LLY holding increased by 40745USD 86,959,123-160USD 40,745 USD 1025.28 USD 1022.87
2025-11-13 (Thursday)84,975USD 86,918,378LLY holding increased by 432522USD 86,918,3780USD 432,522 USD 1022.87 USD 1017.78
2025-11-12 (Wednesday)84,975USD 86,485,856LLY holding increased by 2477871USD 86,485,8560USD 2,477,871 USD 1017.78 USD 988.62
2025-11-11 (Tuesday)84,975LLY holding decreased by -320USD 84,007,985LLY holding increased by 1558426USD 84,007,985-320USD 1,558,426 USD 988.62 USD 966.64
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE00B0M62Q58

Show aggregate share trades of LLY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-26SELL-1601,111.9901,098.100 1,099.489EUR -175,918 814.10 Loss of -45,662 on sale
2025-11-26SELL-1601,111.9901,098.100 1,099.489EUR -175,918 814.10 Loss of -45,662 on sale
2025-11-14SELL-1601,033.6191,007.785 1,010.368EUR -161,659 805.44 Loss of -32,789 on sale
2025-11-11SELL-320999.920965.285 968.748EUR -310,000 802.60 Loss of -53,167 on sale
2025-10-22SELL-160812.430815.940 815.589EUR -130,494 797.91 Loss of -2,829 on sale
2025-09-24SELL-320741.850746.940 746.431EUR -238,858 798.44 Profit of 16,641 on sale
2025-08-28SELL-160731.960738.590 737.927EUR -118,068 799.91 Profit of 9,918 on sale
2025-08-05SELL-320765.950769.940 769.541EUR -246,253 803.45 Profit of 10,852 on sale
2025-07-29SELL-320762.950779.490 777.836EUR -248,908 804.52 Profit of 8,539 on sale
2025-07-02BUY480779.280779.840 779.784EUR 374,296 806.42
2025-06-23SELL-160770.640793.210 790.953EUR -126,552 807.24 Profit of 2,606 on sale
2025-06-13SELL-320819.360825.000 824.436EUR -263,820 807.89 Loss of -5,295 on sale
2025-06-02SELL-160747.120747.370 747.345EUR -119,575 809.91 Profit of 10,010 on sale
2025-05-07SELL-320776.720784.340 783.578EUR -250,745 821.40 Profit of 12,103 on sale
2025-04-25BUY640884.540885.580 885.476EUR 566,705 819.65
2025-04-11BUY480732.410735.840 735.497EUR 353,039 821.68
2025-04-09SELL-2,560753.710754.830 754.718EUR -1,932,078 823.42 Profit of 175,883 on sale
2025-04-08BUY2,400726.240763.500 759.774EUR 1,823,458 824.43
2025-04-04BUY160738.210768.270 765.264EUR 122,442 826.42
2025-03-28SELL-160822.510829.780 829.053EUR -132,648 826.80 Loss of -361 on sale
2025-03-14SELL-320813.480815.210 815.037EUR -260,812 825.85 Profit of 3,462 on sale
2025-03-12SELL-320821.860834.650 833.371EUR -266,679 826.22 Loss of -2,290 on sale
2025-03-07SELL-320869.580908.000 904.158EUR -289,331 825.62 Loss of -25,132 on sale
2025-02-18SELL-160857.200862.730 862.177EUR -137,948 812.00 Loss of -8,029 on sale
2025-02-12SELL-640872.970877.780 877.299EUR -561,471 808.86 Loss of -43,803 on sale
2025-02-05BUY320842.180846.900 846.428EUR 270,857 803.66
2025-02-04BUY800826.070829.040 828.743EUR 662,994 803.24
2024-11-18BUY160727.200734.000 733.320EUR 117,331 850.95
2024-11-07BUY160797.450802.550 802.040EUR 128,326 860.45
2024-10-31BUY160829.740853.500 851.124EUR 136,180 893.57
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19432,0389351,319,85332.7%
2025-09-18547,8181261,290,14742.5%
2025-09-17437,3374271,166,20437.5%
2025-09-16532,6981,8291,463,37436.4%
2025-09-15424,9797011,071,48739.7%
2025-09-12267,121172826,80232.3%
2025-09-11249,8031,484850,46129.4%
2025-09-10415,4421,025989,00842.0%
2025-09-09559,8056671,270,80044.1%
2025-09-08856,0184,6821,937,44744.2%
2025-09-05679,2761,0501,405,23948.3%
2025-09-04337,49153982,75134.3%
2025-09-03214,691496766,15728.0%
2025-09-02430,4772,9771,131,90838.0%
2025-08-29357,538602889,50940.2%
2025-08-28433,6871,0991,113,56838.9%
2025-08-27860,7156,0091,681,35351.2%
2025-08-261,548,46012,1052,955,34852.4%
2025-08-25566,4543,5861,323,24942.8%
2025-08-22749,6151,9571,460,71351.3%
2025-08-21651,6392231,570,06741.5%
2025-08-20679,5542,6981,870,24136.3%
2025-08-19787,9099352,788,74028.3%
2025-08-18756,1431,0951,727,60343.8%
2025-08-151,814,7218363,422,26053.0%
2025-08-141,852,9405,3823,602,82951.4%
2025-08-131,254,2253,4732,774,10045.2%
2025-08-12990,1103,1902,845,89634.8%
2025-08-111,290,0631,6155,196,30224.8%
2025-08-082,448,706300,8706,239,83039.2%
2025-08-074,197,951489,61810,364,29440.5%
2025-08-06440,1441,1201,811,26224.3%
2025-08-05331,460921993,17833.4%
2025-08-04474,9051,4081,273,99537.3%
2025-08-01530,5697,1391,882,09828.2%
2025-07-31882,5063,6702,110,03041.8%
2025-07-30745,6143921,827,43540.8%
2025-07-291,081,8495712,607,24541.5%
2025-07-28304,8417,4601,004,03230.4%
2025-07-25365,4172651,055,27334.6%
2025-07-24321,7997621,167,14727.6%
2025-07-23485,7193,4711,044,91946.5%
2025-07-22241,0983,036874,71727.6%
2025-07-21418,0148541,180,44535.4%
2025-07-18623,4986511,225,33350.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.